KALEY MARINO: Open Payments
NPI 1376021725 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 14 payments from 7 companies in 2025. Trend: 2023 $631 · 2024 $859 · 2025 $261
Food & beverage: $261
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| Almatica Pharma LLC | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: FANAPT, LOREEV XR, REXULTI, Qelbree, VRAYLAR, Auvelity, INVEGA SUSTENNA.
Industry payments across IN — which companies pay providers there.
